126 related articles for article (PubMed ID: 37276927)
1. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract][Full Text] [Related]
2. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
6. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation.
Ma T; Yamada S; Ichwan SJ; Iseki S; Ohtani K; Otsu M; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(3):931-7. PubMed ID: 22166212
[TBL] [Abstract][Full Text] [Related]
7. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
8. RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.
Surget S; Descamps G; Brosseau C; Normant V; Maïga S; Gomez-Bougie P; Gouy-Colin N; Godon C; Béné MC; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C
BMC Cancer; 2014 Jun; 14():437. PubMed ID: 24927749
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin sets a threshold for p53 response to UV radiation.
Maiguel DA; Jones L; Chakravarty D; Yang C; Carrier F
Mol Cell Biol; 2004 May; 24(9):3703-11. PubMed ID: 15082766
[TBL] [Abstract][Full Text] [Related]
10. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract][Full Text] [Related]
11. The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway.
Pfister AS; Keil M; Kühl M
J Biol Chem; 2015 Apr; 290(17):10905-18. PubMed ID: 25759387
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
13. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
14. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
16. Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.
Xiao S; Caglar E; Maldonado P; Das D; Nadeem Z; Chi A; Trinité B; Li X; Saxena A
PLoS One; 2014; 9(10):e109858. PubMed ID: 25313645
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
18. Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.
Nalabothula N; Chakravarty D; Pierce A; Carrier F
Mol Cell Pharmacol; 2010; 2(5):179-189. PubMed ID: 21499441
[TBL] [Abstract][Full Text] [Related]
19. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
20. Chk2 mediates RITA-induced apoptosis.
de Lange J; Verlaan-de Vries M; Teunisse AF; Jochemsen AG
Cell Death Differ; 2012 Jun; 19(6):980-9. PubMed ID: 22158418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
